Literature DB >> 7685165

Identification of SHC as a substrate of the insulin receptor kinase distinct from the GAP-associated 62 kDa tyrosine phosphoprotein.

K S Kovacina1, R A Roth.   

Abstract

Insulin stimulated tyrosine phosphorylation of SHC, a SH2 containing protein, was demonstrated in Chinese hamster ovary cells overexpressing the insulin receptor by immunoblotting with antiphosphotyrosine antibodies and in vivo labeling. Insulin induced tyrosine phosphorylation of SHC occurred very rapidly (within 1 min) with a dose curve which paralleled the autophosphorylation of the insulin receptor. Phosphorylation of SHC appeared to occur to a high stoichiometry since insulin induced the majority of SHC to shift to a higher molecular weight. The tyrosine phosphorylated SHC was not bound by the GTPase activating protein of Ras although a distinct 62 kDa tyrosine phosphorylated protein was found to be associated in the same experiments. It also was not bound to the insulin receptor, phosphatidylinositol 3-kinase or insulin receptor substrate-1.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7685165     DOI: 10.1006/bbrc.1993.1558

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Interaction between cAMP-dependent and insulin-dependent signal pathways in tyrosine phosphorylation in primary cultures of rat hepatocytes.

Authors:  Y Ito; Y Uchijima; M Ariga; T Seki; A Takenaka; F Hakuno; S I Takahashi; T Ariga; T Noguchi
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

Review 2.  Binding of SH2 containing proteins to the insulin receptor: a new way for modulating insulin signalling.

Authors:  F Liu; R A Roth
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

3.  Sch proteins are localized on endoplasmic reticulum membranes and are redistributed after tyrosine kinase receptor activation.

Authors:  L V Lotti; L Lanfrancone; E Migliaccio; C Zompetta; G Pelicci; A E Salcini; B Falini; P G Pelicci; M R Torrisi
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

4.  Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites.

Authors:  P van der Geer; S Wiley; G D Gish; V K Lai; R Stephens; M F White; D Kaplan; T Pawson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

5.  Dexamethasone enhances insulin-like growth factor-I effects on skeletal muscle cell proliferation. Role of specific intracellular signaling pathways.

Authors:  F Giorgino; R J Smith
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

6.  Selective impairment of insulin signalling in the hypothalamus of obese Zucker rats.

Authors:  J B C Carvalheira; E B Ribeiro; E P Araújo; R B Guimarães; M M Telles; M Torsoni; J A R Gontijo; L A Velloso; M J A Saad
Journal:  Diabetologia       Date:  2003-11-05       Impact factor: 10.122

7.  Effect of nutritional state on the formation of a complex involving insulin receptor IRS-1, the 52 kDa Src homology/collagen protein (Shc) isoform and phosphatidylinositol 3'-kinase activity.

Authors:  J Dupont; M Derouet; J Simon; M Taouis
Journal:  Biochem J       Date:  1998-10-15       Impact factor: 3.857

8.  Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain.

Authors:  T A Gustafson; W He; A Craparo; C D Schaub; T J O'Neill
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

9.  Involvement of Shc in insulin- and epidermal growth factor-induced activation of p21ras.

Authors:  G J Pronk; A M de Vries-Smits; L Buday; J Downward; J A Maassen; R H Medema; J L Bos
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

10.  Shc, Grb2, Sos1, and a 150-kilodalton tyrosine-phosphorylated protein form complexes with Fms in hematopoietic cells.

Authors:  M N Lioubin; G M Myles; K Carlberg; D Bowtell; L R Rohrschneider
Journal:  Mol Cell Biol       Date:  1994-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.